Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDD.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KR.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KR.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MD.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
XDD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XDD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.64.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.64.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.64.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.64.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDP.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDP.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KR.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KR.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KZ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KZ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KZ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KS.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KS.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KS.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KS.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
HN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.4.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used